On March 19th, 2018, Health Canada released a report summarizing the feedback it received from the 60-day public consultation launched on November 21st, 2017, regarding the approach to legalization and regulation of cannabis.[1] During this consultation period, public comments were considered, and Health Canada also held meetings with stakeholders who will be affected by the regulations, provincial and territorial representatives, and Aboriginal organizations.
This report clearly shows that Health Canada plans to maintain strict limits on cannabis production and packaging. However, it is also evident that Canadians felt that it is important for the federal government to provide a framework that will allow for a diverse, competitive and legal industry.
In order for the Canadian cannabis industry to be thriving, prevent the illicit market from profiting, and keep up with the global competition, small and large cannabis companies in Canada must remain relevant and innovative, which means being able to develop new technologies and differentiate their products from their competitors all while staying within a regulatory framework. This also means having the ability to partner with international companies and ensuring products and technologies from these global partners meet the standards set out by Health Canada.
If you have questions about meeting the Canadian cannabis regulations, contact us at info@canndeltav2:8890 to learn how CannDelta Inc. can help.
[1] https://www.canada.ca/en/health-canada/services/publications/drugs-health-products/summary-comments-public-consultation-regulation-cannabis.html
